reports
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conferen...
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference CHASKA, Minn., April 22, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the upcoming CDMO Live 2025 conference. Billed as a premiere partnering event for the biopharma outsourcing industry, CDMO Live will take place May 7-8, 2025, in Rotterdam, Netherlands. During the conference, Jackie Klecker, Lifecore’s executive vice president, quality and development ...
AMG Announces Investment in Verition Fund Management
AMG Announces Investment in Verition Fund Management AMG to acquire a minority equity interest in Verition, a global multi-strategy investment firm with $12.6 billion in AUMVerition’s management will retain a substantial majority of the firm’s equity and continue to lead Verition as an independent firm, in line with AMG’s partnership approachPartnership further diversifies AMG’s business and increases its exposure to alternative strategies WEST PALM BEACH, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- AMG, a strategic partner to leading independent investment management firms globally, today ...
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)...
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CHASKA, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Lifecore granted a restricted stock unit (“RSU”) award with respect to 45,000 shares of its common stock, an option for 210,000 shares of stock, an RSU for 170,000 shares of common stock, and a performance stock unit (“PSU”) award for up to 370,000 shares of its common stock to Thomas D. Salus, Lifecore’s newly hi...
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Admini...
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry Significantly Elevates Lifecore’s Capabilities Across Corporate Governance, Transactional Activities, and SEC Reporting and Compliance CHASKA, Minn., April 14, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has appointed Th...
Crown Castle Announces First Quarter 2025 Earnings Conference Call Det...
Crown Castle Announces First Quarter 2025 Earnings Conference Call Details HOUSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") plans to release its first quarter 2025 results on Wednesday, April 30, 2025, after the market closes. In conjunction with the release, Crown Castle has scheduled a conference call for Wednesday, April 30, 2025, at 5:00 p.m. eastern time. A listen only live audio webcast of the conference call, along with any supplemental materials, can be accessed on the Crown Castle website at . Participants may join the conference call by...
Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Result...
Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update -- Recorded Revenues of $35.2 Million for Q3 Fiscal 2025 -- -- Signed Multiple Development Agreements with New and Existing Customers -- -- Strengthened Balance Sheet through Sale of Excess Capital Equipment, Raising Approximately $17.0 Million -- Conference Call Today at 4:30pm ET CHASKA, Minn., April 03, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announ...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
LOPE GRAND CANYON EDUCATION INC.
LNDC LANDEC CORP.
HOO HERBALIFE NUTRITION LTD.
DLTR DOLLAR TREE INC.
DG DOLLAR GENERAL CORPORATION
CAAS CHINA AUTOMOTIVE SYSTEMS ADS (N SHARES)
BFAM BRIGHT HORIZONS FAMILY SOLUTIONS INC.
AZO AUTOZONE INC.
ADMA ADMA BIOLOGICS INC
ACU ACME UNITED CORP.
OSTK OVERSTOCK.COM INC.
UVV UNIVERSAL CORP
FDP FRESH DEL MONTE PRODUCE INC.
TATT TAT TECHNOLOGIES LTD.
WMK WEIS MARKETS INC.
KINS KINGSTONE COS. INC.
NC NACCO INDUSTRIES INC. CL A
CHCI COMSTOCK HOLDING COMPANIES
VLGEA VILLAGE SUPER MARKET INC. CL A
LAUR LAUREATE EDUCATION INC. CLASS A
CMCL CALEDONIA MINING CORPORATION
ABT ABBOTT LABORATORIES
BRP BRP GROUP
GRPN GROUPON INC.
CNXC CONCENTRIX
DRVN DRIVEN BRANDS HOLDINGS
ALHC ALIGNMENT HEALTHCARE INC
ADSE ADS TEC ENERGY PLC
KLG_w WK KELLOGG CO
TRVG TRIVAGO N.V.
BG BUNGE LIMITED
IDR IDAHO STRATEGIC RESOURCES INC
DBD DIEBOLD NIXDORF INCORPORATED
CCB CHASE CAPITAL VIII CAP SEC H 8.25%
MNPR MONOPAR THERAPEUTICS INC.
AEVA AEVA TECHNOLOGIES INC.
ORLY OREILLY AUTOMOTIVE INC CDA
Lifecore Biomedical to Report Financial Results for Third Quarter of F...
Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025 Webcast Scheduled for Thursday, April 3 at 4:30 p.m. Eastern CHASKA, Minn., March 27, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the third quarter of fiscal year 2025 on Thursday, April 3, 2025, after market close. At 4:30 p.m. Eastern Time that day, members of Lifecore’s senior management team will host a webcast to disc...
Crown Castle Announces CEO Transition
Crown Castle Announces CEO Transition Daniel Schlanger, Current Executive Vice President and CFO, Appointed Interim President and CEO Search Underway to Identify Successor CEO Reaffirms All Recently Announced Financial Guidance and Capital Allocation Policies Highly Confident in Value-Maximizing Transformation into a Pure-Play US Tower Company HOUSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) (“Company” or “Crown Castle”) today announced that the Company’s Board of Directors (Board) has appointed Dan Schlanger, Executive...
Moody's Ratings affirms Crown Castle Inc.'s Baa3 ratings, changes outl...
Moody's Ratings (Moody's) today affirmed Crown Castle Inc.'s ("Crown Castle" or the "the REIT") Baa3 senior unsecured debt rating and changed the outlook to negative from stable. In the same rating action, we affirmed the REIT's Prime-3 commercial paper (CP) rating, (P)Baa3 senior unsecured shelf ra...
Crown Castle Appoints Katherine Motlagh to its Board of Directors
Crown Castle Appoints Katherine Motlagh to its Board of Directors HOUSTON, March 17, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") announced today the appointment of Katherine Motlagh to its board of directors. Ms. Motlagh’s appointment is effective today, March 17, 2025. Ms. Motlagh previously served as CFO of CyrusOne LLC and CFO of the Europe, Africa and Latin America regions of American Tower Corporation. She currently serves on the board of directors of EVgo, Inc., where she serves as Chair of the audit committee. “Katherine brings extensive financial, inv...
Crown Castle Names Sunit Patel as Chief Financial Officer
Crown Castle Names Sunit Patel as Chief Financial Officer HOUSTON, March 17, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") announced today the appointment of Sunit Patel to the position of Executive Vice President and Chief Financial Officer (CFO), effective April 1, 2025. Mr. Patel will be leaving his position on Crown Castle’s Board of Directors, effective March 17, 2025. "We look forward to welcoming Sunit Patel to the Crown Castle team,” said Steven Moskowitz, Crown Castle's Chief Executive Officer. "Sunit brings unique, extensive telecommunications industry...
Moody's affirms Crown Castle Inc.'s Baa3 ratings, changes outlook to n...
Moody's Ratings (Moody's) today affirmed Crown Castle Inc.'s ("Crown Castle" or the "the REIT") Baa3 senior unsecured debt rating and changed the outlook to negative from stable. In the same rating action, we affirmed the REIT's Prime-3 commercial paper (CP) rating, (P)Baa3 senior unsecured shelf ra...
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Suppor...
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM) Lifecore to Carry Out Tech Transfer and Analytical Method Activities, including Filling of Pilot Batch CHASKA, Minn. and MINNEAPOLIS, March 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and Human...
Crown Castle Announces Agreement To Sell Fiber Segment to EQT and Zayo...
Crown Castle Announces Agreement To Sell Fiber Segment to EQT and Zayo, Reports Fourth Quarter and Full Year 2024 Results, and Provides Outlook for Full Year 2025 Successfully Concludes Strategic Review with Agreement to Sell Small Cells and Fiber Solutions for $8.5 Billion Results in Crown Castle as the Only Pure-Play, Publicly-Traded US Tower Company Increases Capital Efficiency with Updated Capital Allocation Framework, Including Anticipated New Dividend Policy and Proposed Approximately $3.0 Billion Share Repurchase Program HOUSTON, March 13, 2025 (GLOBE NEWSWIRE) -- Crown Castle I...
Crown Castle Announces Updated Fourth Quarter 2024 Earnings Conference...
Crown Castle Announces Updated Fourth Quarter 2024 Earnings Conference Call Details HOUSTON, March 12, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") plans to reschedule the release of its fourth quarter 2024 results to Thursday, March 13, 2025, after the market closes. As previously disclosed, Crown Castle is pursuing a review of strategic alternatives that may be available with respect to its Fiber segment. Due to the significant demands related to the strategic review, Crown Castle has rescheduled its conference call for Thursday, March 13, 2025 at 5:00 p.m. ea...
Crown Castle Declares Quarterly Common Stock Dividend
Crown Castle Declares Quarterly Common Stock Dividend HOUSTON, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") announced today that its Board of Directors has declared a quarterly cash dividend of $1.565 per common share. The quarterly dividend will be payable on March 31, 2025 to common stockholders of record at the close of business on March 14, 2025. Future dividends are subject to the approval of Crown Castle's Board of Directors. ABOUT CROWN CASTLE Crown Castle owns, operates and leases more than 40,000 cell towers and approximately 90,000 r...
Lifecore Biomedical to Participate in Upcoming Investor and Industry C...
Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences CHASKA, Minn., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in multiple upcoming investor conferences and industry events. Details regarding Lifecore’s participation are as follows: TD Cowen 45th Annual Health Care ConferenceDetails: Paul Josephs, chief executive officer, will deliver a corporate presentation and Lifecore management will ...
Crown Castle Announces Fourth Quarter 2024 Earnings Conference Call De...
Crown Castle Announces Fourth Quarter 2024 Earnings Conference Call Details HOUSTON, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") plans to release its fourth quarter 2024 results on Wednesday, March 12, 2025, after the market closes. In conjunction with the release, Crown Castle has scheduled a conference call for Wednesday, March 12, 2025, at 5:00 p.m. eastern time. A listen only live audio webcast of the conference call, along with any supplemental materials, can be accessed on the Crown Castle website at . Participants may join the conference call b...
Moody's Ratings affirms Affiliated Managers Group's A3 senior unsecure...
Moody's Ratings (Moody's) has affirmed Affiliated Managers Group, Inc.'s (AMG) senior unsecured rating at A3. We have also affirmed the senior unsecured shelf rating at (P)A3, junior subordinate rating at Baa1, and junior subordinate shelf rating at (P)Baa1. The outlook remains stable. RATINGS RAT...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.